Clinical Trial Update: REMUNE HIV/AIDS Vaccine Phase II Pediatric Safety & Efficacy Clinical Study [Phase 2]

View source ↗

Summary

Phase II pediatric safety and efficacy study of the REMUNE HIV/AIDS vaccine; current status is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acquired Immunodeficiency Syndrome
• HIV Infection

Drugs mentioned

• Remune

Snippet

Sponsor: Immune Response BioPharma, Inc. | Conditions: HIV/AIDS | Phase 2 | Status: UNKNOWN